Board Certified Ambulatory Care Pharmacist (BCACP) Exam — Questions and Answers

Question 1: Colesevelam (a bile acid sequestrant) is unique among lipid-lowering agents because it also reduces which other cardiovascular risk marker?

Hemoglobin A1c in type 2 diabetes (Correct answer)
Lipoprotein(a)
C-reactive protein
Triglycerides

Correct answer: Hemoglobin A1c in type 2 diabetes

Colesevelam has FDA approval for improving glycemic control in type 2 diabetes, making it a dual-benefit agent in diabetic patients with dyslipidemia.

Question 2: A patient on lisinopril develops a dry cough. The pharmacist recommends switching to which medication?

Losartan (Correct answer)
Captopril
Ramipril
Enalapril

Correct answer: Losartan

ACE inhibitor–induced cough (due to bradykinin accumulation) is a class effect; ARBs such as losartan do not affect bradykinin and are the preferred switch.

Question 3: A patient on warfarin has a new prescription for fluconazole for a vaginal infection. What is the expected interaction?

No clinically significant interaction exists
Fluconazole decreases warfarin absorption
Fluconazole decreases warfarin effect by inducing CYP2C9
Fluconazole increases warfarin effect by inhibiting CYP2C9 (Correct answer)

Correct answer: Fluconazole increases warfarin effect by inhibiting CYP2C9

Fluconazole is a potent CYP2C9 inhibitor, reducing warfarin metabolism and significantly increasing INR.

Question 4: For a patient with T2DM and established ASCVD, which medication class has the strongest evidence for reducing cardiovascular mortality as a first add-on to metformin?

DPP-4 inhibitors
GLP-1 receptor agonists or SGLT2 inhibitors (Correct answer)
Sulfonylureas
Thiazolidinediones

Correct answer: GLP-1 receptor agonists or SGLT2 inhibitors

ADA guidelines recommend GLP-1 receptor agonists or SGLT2 inhibitors with proven cardiovascular benefit as preferred add-ons to metformin in patients with established ASCVD.

Question 5: A clinical trial evaluates a new medication for stroke prevention in patients with atrial fibrillation. The results for the primary outcome of ischemic stroke are reported as a Hazard Ratio (HR) of 0.80 with a 95% Confidence Interval (CI) of 0.65 to 1.05. Which of the following is the most accurate interpretation of this finding?

The p-value must be less than 0.05.
The result is not statistically significant. (Correct answer)
The new medication is inferior to the comparator for stroke prevention.
The new medication is superior to the comparator for stroke prevention.

Correct answer: The result is not statistically significant.

For a ratio metric like a Hazard Ratio (HR), Relative Risk (RR), or Odds Ratio (OR), the null value (representing no difference between groups) is 1.0. A 95% Confidence Interval indicates a range where the true effect is likely to lie. Because this 95% CI (0.65 to 1.05) crosses 1.0, we cannot exclude the possibility of no difference. Therefore, the result is not statistically significant at the p<0.05 level.

Question 6: A community pharmacy initiates a program to call all patients with uncontrolled hypertension before their next scheduled appointment. This is an example of:

Utilization management
Chronic disease surveillance
Tertiary prevention
Proactive panel management (Correct answer)

Correct answer: Proactive panel management

Proactive panel management involves identifying and reaching out to at-risk patients before problems escalate, rather than waiting for them to present.

Question 7: Which antihypertensive drug class is the recommended first-line therapy for a patient with hypertension and proteinuric diabetic nephropathy?

Thiazide diuretics
Beta-blockers
ACE inhibitors or ARBs (Correct answer)
Calcium channel blockers

Correct answer: ACE inhibitors or ARBs

ACE inhibitors and ARBs reduce intraglomerular pressure and proteinuria in diabetic nephropathy, providing renoprotection beyond blood pressure lowering.

Question 8: Which DPP-4 inhibitor requires dose adjustment in renal impairment and has the most documented clinical experience?

Alogliptin
Sitagliptin (Correct answer)
Saxagliptin
Linagliptin

Correct answer: Sitagliptin

Sitagliptin was the first DPP-4 inhibitor approved and requires dose reduction in moderate to severe renal impairment; linagliptin is the only DPP-4i that does NOT require renal dose adjustment.

Question 9: Which non-HDL cholesterol target is recommended for very high-risk cardiovascular patients per current guidelines?

<70 mg/dL
<55 mg/dL
<130 mg/dL
<100 mg/dL (Correct answer)

Correct answer: <100 mg/dL

Non-HDL-C goal for very high-risk patients is <100 mg/dL, which corresponds to an LDL-C goal of <70 mg/dL plus 30 mg/dL.

Question 10: Which is a guideline-recommended first-line option for initial treatment of acute DVT in a patient with adequate renal function and no active cancer?

Warfarin 5 mg daily alone without heparin bridging
Aspirin 325 mg daily for 3 months
Unfractionated heparin alone without transition to an oral agent
Rivaroxaban 15 mg twice daily for 21 days, then 20 mg daily (Correct answer)

Correct answer: Rivaroxaban 15 mg twice daily for 21 days, then 20 mg daily

Rivaroxaban monotherapy using a dual-dose regimen (15 mg BID x21 days, then 20 mg daily) is guideline-recommended for acute DVT without requiring initial parenteral therapy.

Question 11: According to ACC/AHA guidelines, which 10-year ASCVD risk threshold defines high risk and warrants statin initiation in primary prevention?

≥10%
≥15%
≥5%
≥7.5% (Correct answer)

Correct answer: ≥7.5%

A 10-year ASCVD risk ≥7.5% is the threshold for considering statin therapy in primary prevention per ACC/AHA guidelines.

Question 12: Which type of study is most susceptible to recall bias?

Case-control study (Correct answer)
Randomized controlled trial
Crossover trial
Prospective cohort study

Correct answer: Case-control study

Case-control studies rely on participants recalling past exposures, making them vulnerable to recall bias.

Question 13: A patient on long-term opioid therapy for chronic pain presents for a routine monitoring visit. Which of the following is a recommended component of ongoing monitoring according to opioid prescribing guidelines?

Urine drug screening and prescription drug monitoring program (PDMP) check (Correct answer)
Routine cardiac stress testing due to QTc prolongation from all opioids
Weekly liver function tests due to opioid hepatotoxicity risk
Monthly complete blood count to monitor for opioid-induced cytopenias

Correct answer: Urine drug screening and prescription drug monitoring program (PDMP) check

CDC guidelines and state-level opioid prescribing policies recommend urine drug testing (to verify adherence and screen for undisclosed substance use) and checking the Prescription Drug Monitoring Program (PDMP) at each visit or at minimum at the start of therapy and periodically thereafter. CBCs and LFTs are not routinely indicated for opioid monitoring. QTc monitoring is specific to methadone, not all opioids.

Question 14: A patient newly diagnosed with hypertension has a blood pressure of 158/96 mmHg and no compelling indications. According to ACC/AHA guidelines, what is the preferred initial therapy?

An ARB plus a thiazide diuretic combination
A beta-blocker as first-line monotherapy
A thiazide diuretic, ACE inhibitor/ARB, or calcium channel blocker (Correct answer)
Alpha-blocker monotherapy

Correct answer: A thiazide diuretic, ACE inhibitor/ARB, or calcium channel blocker

ACC/AHA guidelines recommend thiazide diuretics, ACE inhibitors/ARBs, or long-acting calcium channel blockers as first-line options for hypertension without compelling indications.

Question 15: The Pharmacy Quality Alliance (PQA) measure 'Medication Adherence for Diabetes Medications' uses which metric to assess adherence?

Patient-reported adherence score ≥85%
Medication Possession Ratio (MPR) >0.70
Proportion of Days Covered (PDC) ≥0.80 (Correct answer)
Number of refills dispensed per year ≥10

Correct answer: Proportion of Days Covered (PDC) ≥0.80

PQA adherence measures use PDC ≥0.80 (80%) as the threshold for 'adherent,' as PDC is considered more rigorous than MPR.

Question 16: Under HIPAA, which of the following activities by a pharmacist is permitted without specific patient authorization?

Selling patient data to a pharmaceutical marketing company
Disclosing PHI to the patient's treating cardiologist for treatment purposes (Correct answer)
Sharing patient medication lists with the patient's employer
Posting patient cases on social media for educational purposes

Correct answer: Disclosing PHI to the patient's treating cardiologist for treatment purposes

HIPAA's Treatment, Payment, and Operations (TPO) exceptions allow disclosure of PHI to other treating providers without specific patient authorization.

Question 17: Which insulin type has the longest duration of action and is typically dosed once or twice daily as basal insulin?

Insulin degludec (Correct answer)
Insulin NPH
Insulin lispro
Regular insulin

Correct answer: Insulin degludec

Insulin degludec (Tresiba) has an ultra-long duration of action (>42 hours), making it suitable for once-daily basal dosing with a flat peakless profile.

Question 18: A patient with Crohn's disease involving the ileum is in remission on azathioprine monotherapy. Which biologic agent would be most appropriate to ADD for a patient with moderate-to-severe disease who fails to maintain remission on an immunomodulator alone?

Vedolizumab (anti-integrin)
All three options are equally preferred as initial biologic therapy per ACG guidelines
Infliximab (anti-TNF-alpha) (Correct answer)
Ustekinumab (anti-IL-12/23)

Correct answer: Infliximab (anti-TNF-alpha)

Anti-TNF agents (infliximab, adalimumab) are the most established and guideline-preferred first-line biologic therapy for moderate-to-severe Crohn's disease, often combined with an immunomodulator (combo therapy reduces immunogenicity). Vedolizumab and ustekinumab are effective alternatives, particularly for patients who fail or cannot tolerate anti-TNF agents, but infliximab has the most robust long-term efficacy and safety data as an initial biologic in Crohn's disease.

Question 19: Which statistical test is most appropriate for comparing means across three or more independent groups in a clinical trial?

Pearson correlation
Paired t-test
One-way ANOVA (Correct answer)
Chi-square test

Correct answer: One-way ANOVA

One-way ANOVA compares means among three or more independent groups simultaneously.

Question 20: A patient with COPD was just discharged from the hospital and is prescribed a new inhaled long-acting bronchodilator. Which pharmacist intervention is MOST critical within 48–72 hours post-discharge?

Verify the insurance prior authorization has been submitted
Confirm the patient has the inhaler, understands the correct technique, and knows when to call if symptoms worsen (Correct answer)
Check if the patient has a new pharmacy benefit card
Wait for the next scheduled office visit to address medication counseling

Correct answer: Confirm the patient has the inhaler, understands the correct technique, and knows when to call if symptoms worsen

Transitional care pharmacist outreach within 72 hours of discharge addresses medication access, proper technique, and red flag education to prevent readmission.

Question 21: A patient receives idarucizumab for dabigatran reversal. Which statement is correct?

Idarucizumab takes 24 hours to achieve full reversal
Idarucizumab requires renal dose adjustment
Idarucizumab is a specific reversal agent for dabigatran (Correct answer)
Idarucizumab reverses all DOACs nonselectively

Correct answer: Idarucizumab is a specific reversal agent for dabigatran

Idarucizumab (Praxbind) is a humanized monoclonal antibody fragment that specifically and rapidly reverses dabigatran's anticoagulant effect.

Question 22: Which of the following BEST describes the concept of 'concordance' in medication management?

The prescriber's confirmation that the patient filled the prescription
A mutually agreed-upon plan resulting from a therapeutic alliance between patient and clinician (Correct answer)
The patient's strict adherence to the prescribed regimen
The pharmacist's documentation of patient compliance

Correct answer: A mutually agreed-upon plan resulting from a therapeutic alliance between patient and clinician

Concordance reflects a partnership where the patient's views are respected and the final treatment plan is agreed upon jointly, not merely prescribed.

Question 23: A clinical trial for a new heart failure medication reports a statistically significant reduction in its primary composite endpoint of 'cardiovascular death, hospitalization for heart failure, or urgent heart failure visit.' An analysis of the individual components reveals the benefit was driven almost exclusively by a reduction in urgent heart failure visits, with no significant difference in CV death or hospitalizations. What is the most appropriate clinical interpretation?

The drug is likely to show a mortality benefit if the trial is extended for a longer duration.
The composite endpoint is invalid and the study results should be disregarded entirely.
The benefit of the drug is primarily related to reducing less severe events like urgent heart failure visits. (Correct answer)
The drug is proven effective at reducing mortality and hospitalizations in patients with heart failure.

Correct answer: The benefit of the drug is primarily related to reducing less severe events like urgent heart failure visits.

When evaluating a composite endpoint, it is crucial to examine the individual components to understand the true effect of the intervention. A significant result for the composite does not automatically apply to all its components. In this case, the benefit was driven by the softest, least severe endpoint, so the most accurate interpretation is that the drug's main effect is on reducing urgent HF visits, not necessarily on the more severe outcomes of hospitalization or death.

Question 24: Which lifestyle intervention has the MOST evidence for reducing LDL-C without medication?

Limiting alcohol intake
Increasing aerobic exercise
Increasing dietary fiber
Reducing dietary saturated fat (Correct answer)

Correct answer: Reducing dietary saturated fat

Reducing dietary saturated fat has the strongest evidence for lowering LDL-C among lifestyle interventions, replacing it with unsaturated fats provides additional benefit.

Question 25: Which antihypertensive drug is preferred in a patient with hypertension and a concurrent migraine prophylaxis indication?

Losartan
Propranolol (Correct answer)
Chlorthalidone
Amlodipine

Correct answer: Propranolol

Propranolol is FDA-approved for migraine prophylaxis and also lowers blood pressure, making it an ideal single-agent choice for patients with both conditions.

Question 26: A 72-year-old woman with hypertension, osteoporosis, and no prior CV events has a 10-year ASCVD risk of 9%. The clinician and patient are uncertain about statin therapy. What is the most appropriate next step?

Start aspirin therapy instead of statin
Use risk-enhancing factors to guide the statin discussion (Correct answer)
Defer all treatment for 2 years
Start high-intensity statin immediately

Correct answer: Use risk-enhancing factors to guide the statin discussion

For borderline-risk patients (7.5–20%), ACC/AHA guidelines recommend using risk-enhancing factors to refine the statin initiation decision.

Question 27: Which type of bias occurs when patients and investigators both know the treatment assignment in a clinical trial?

Attrition bias
Performance bias (Correct answer)
Detection bias
Selection bias

Correct answer: Performance bias

Performance bias results from differential care or behaviors when treatment allocation is unmasked to both participants and caregivers.

Question 28: What is the purpose of providing Tdap (rather than Td) to adults who have not previously received it?

To protect against pertussis (whooping cough) in addition to tetanus and diphtheria (Correct answer)
To replace annual flu vaccination
To prevent hepatitis A
To provide additional tetanus coverage

Correct answer: To protect against pertussis (whooping cough) in addition to tetanus and diphtheria

Tdap includes the pertussis component, which is important for reducing community transmission and protecting vulnerable contacts such as infants.

Question 29: Dabigatran is contraindicated for stroke prevention in atrial fibrillation when the patient's CrCl falls below which threshold?

40 mL/min
50 mL/min
15 mL/min
30 mL/min (Correct answer)

Correct answer: 30 mL/min

Dabigatran is contraindicated in nonvalvular AF when CrCl is below 30 mL/min because its approximately 80% renal elimination creates high risk of drug accumulation and serious bleeding.

Question 30: Which financial model best describes billing using CPT codes 99213 and 99214 for incident-to services provided by a pharmacist in a physician's office?

Bundle payment model
Global billing
Incident-to billing under the supervising physician's NPI (Correct answer)
Direct pharmacist billing under the pharmacist's own NPI

Correct answer: Incident-to billing under the supervising physician's NPI

Incident-to billing allows pharmacist services to be billed under the supervising physician's NPI when specific CMS requirements are met, including direct supervision.

Question 31: A pharmacist is counseling a patient starting insulin glargine. Which statement about insulin glargine storage is correct?

Opened vials must be discarded after 14 days
Unopened pens can be stored at room temperature indefinitely
Insulin glargine must always be refrigerated, even after opening
Once opened, insulin glargine can be kept at room temperature for up to 28 days (Correct answer)

Correct answer: Once opened, insulin glargine can be kept at room temperature for up to 28 days

Once opened (in-use), insulin glargine vials and pens can be stored at room temperature (below 86°F/30°C) for up to 28 days.

Question 32: A pharmacist in a primary care clinic spends 25 minutes during a calendar month providing non-face-to-face care coordination for a Medicare patient with type 2 diabetes and heart failure. This includes telephone calls and medication reconciliation. Which CPT® code is the most appropriate to bill for these services?

99491 (CCM, 30 min by Physician/QHP)
99605 (MTM Service, Initial)
99490 (Chronic Care Management, First 20 min) (Correct answer)
99211 (Level 1 E/M Office Visit)

Correct answer: 99490 (Chronic Care Management, First 20 min)

CPT® code 99490 is designated for at least 20 minutes of clinical staff time per calendar month for non-face-to-face Chronic Care Management (CCM) services for patients with two or more chronic conditions. Since the pharmacist spent 25 minutes, this code is appropriate. 99211 is for a face-to-face visit. 99605 is for an initial MTM encounter. 99491 is for at least 30 minutes of time spent personally by a physician or other qualified healthcare professional, not clinical staff.

Question 33: Which of the following BEST describes the role of a BCACP pharmacist in a patient-centered medical home (PCMH)?

Serving as an integrated care team member providing medication management and chronic disease optimization (Correct answer)
Dispensing medications and processing refills
Reviewing charts without direct patient interaction
Acting as the primary decision-maker for all drug therapy

Correct answer: Serving as an integrated care team member providing medication management and chronic disease optimization

In a PCMH, the ambulatory care pharmacist functions as an integrated team member who collaborates with providers and patients to optimize medication therapy and chronic disease outcomes.

Question 34: A patient is newly prescribed digoxin for rate control in atrial fibrillation with HFrEF. Which serum digoxin level range is associated with optimal outcomes in HFrEF patients?

0.5–0.9 ng/mL (Correct answer)
2.0–3.0 ng/mL
1.0–2.0 ng/mL
Any level below 2.0 ng/mL is acceptable

Correct answer: 0.5–0.9 ng/mL

Post-hoc analyses of the DIG trial showed that digoxin levels of 0.5–0.9 ng/mL are associated with reduced hospitalizations and mortality in HFrEF, while higher levels increase mortality risk.

Question 35: A pharmacist is managing HIV PrEP in a patient who is unable to adhere to daily oral therapy. Which alternative is FDA-approved for HIV pre-exposure prophylaxis?

Maraviroc daily oral dosing
Cabotegravir extended-release injectable (Apretude) given every 2 months (Correct answer)
Dolutegravir oral weekly dosing
Rilpivirine monthly injection

Correct answer: Cabotegravir extended-release injectable (Apretude) given every 2 months

Cabotegravir long-acting injectable (Apretude) is FDA-approved for PrEP administered as an injection every 2 months after initial loading doses.

Question 36: A cohort study follows patients with and without statin use over 10 years to assess cardiovascular events. What measure of association is most appropriate to report?

Odds ratio (OR)
Relative risk (RR) (Correct answer)
Number needed to treat (NNT)
Hazard ratio (HR) only in case-control studies

Correct answer: Relative risk (RR)

Relative risk is the preferred measure of association in cohort studies with known incidence rates.

Question 37: A patient with gastroesophageal reflux disease (GERD) has had an inadequate response to lifestyle modifications. According to a step-up approach, which therapy should be tried FIRST before escalating to a proton pump inhibitor (PPI)?

Prokinetic agent such as metoclopramide
Sucralfate four times daily
Antacid therapy alone is no longer recommended in any GERD patient
H2 receptor antagonist (H2RA) taken as needed or regularly (Correct answer)

Correct answer: H2 receptor antagonist (H2RA) taken as needed or regularly

The step-up approach to GERD management begins with lifestyle modifications, then antacids or H2 receptor antagonists (H2RAs) for mild or intermittent symptoms before advancing to PPIs for moderate-to-severe or frequent symptoms. H2RAs (e.g., famotidine) are appropriate as a step between antacids and PPIs. Sucralfate is used primarily for peptic ulcer disease, not GERD. Metoclopramide has a limited and cautious role due to neurological adverse effects.

Question 38: A patient with type 1 diabetes uses a continuous glucose monitor (CGM). Their recent 14-day report shows the following data: Time in Range (70-180 mg/dL) is 65%, Time Below Range (<70 mg/dL) is 6%, and Time Above Range (>180 mg/dL) is 29%. According to the international consensus on CGM targets, which metric should be the primary focus for improvement?

A. Increasing Time in Range to >70% (Correct answer)
C. Decreasing Time Above Range to <20%
D. Increasing Mean Glucose
B. Decreasing Time Below Range to <1%

Correct answer: A. Increasing Time in Range to >70%

The international consensus recommends a target Time in Range (TIR) of >70% for most adults with type 1 or type 2 diabetes. While reducing time below range is critical for safety (target <4% for level 1 and <1% for level 2 hypoglycemia), the patient is only slightly above the general target. The primary goal is to increase the overall time spent in the target glycemic range, which will inherently address the time spent above range. Increasing mean glucose would be counterproductive.

Question 39: A patient reports they have been taking double doses of their antidepressant to 'feel better faster.' The pharmacist's FIRST action should be:

Non-judgmentally explore the patient's symptoms, expectations, and understanding of how antidepressants work (Correct answer)
Immediately call the prescriber to report misuse
Document the incident and dispense without comment
Warn the patient about serotonin syndrome without further discussion

Correct answer: Non-judgmentally explore the patient's symptoms, expectations, and understanding of how antidepressants work

Non-judgmental exploration of the patient's reasoning reveals misunderstanding about antidepressant onset, allowing targeted education and safety counseling.

Question 40: A 34-year-old patient with moderate persistent asthma is currently on a low-dose inhaled corticosteroid (ICS) alone but continues to have symptoms 4 days per week. According to GINA guidelines, what is the most appropriate step-up therapy?

Add an oral leukotriene receptor antagonist and discontinue the ICS
Switch to a short-acting beta-agonist (SABA) as needed only
Add a long-acting beta-agonist (LABA) to the existing low-dose ICS (Correct answer)
Initiate systemic corticosteroids for 14 days

Correct answer: Add a long-acting beta-agonist (LABA) to the existing low-dose ICS

GINA Step 3 recommends adding a LABA to a low-dose ICS (combination therapy) as the preferred step-up for moderate persistent asthma inadequately controlled on ICS alone. ICS/LABA combinations improve lung function and reduce exacerbations more effectively than increasing ICS dose alone.

Question 41: In a direct primary care (DPC) model that includes pharmacist services, patients pay a monthly membership fee. The primary advantage of this model for pharmacists is:

Elimination of insurance billing and administrative overhead (Correct answer)
Automatic Medicare Part B reimbursement
Guaranteed high volume of insured patients
Mandatory PBM contracting for drug dispensing

Correct answer: Elimination of insurance billing and administrative overhead

DPC replaces insurance-based billing with direct membership fees, dramatically reducing administrative burden and allowing more time for patient care.

Question 42: Which medication used for opioid use disorder (OUD) requires enrollment in the DEA X-waiver program (prior to 2023 regulations) for office-based prescribing?

Buprenorphine/naloxone (Correct answer)
Naltrexone
Methadone (office-based)
Clonidine

Correct answer: Buprenorphine/naloxone

Buprenorphine/naloxone previously required a DEA X-waiver for office-based prescribing for OUD, unlike methadone which required an OTP clinic.

Question 43: A patient with recurrent UTIs requests prophylaxis. Which regimen is evidence-based for continuous antibiotic prophylaxis?

Ciprofloxacin 500 mg twice daily
Doxycycline 100 mg twice daily
Amoxicillin-clavulanate 875 mg daily
Nitrofurantoin 50–100 mg daily at bedtime (Correct answer)

Correct answer: Nitrofurantoin 50–100 mg daily at bedtime

Nitrofurantoin at low doses taken nightly is a well-established option for continuous prophylaxis of recurrent uncomplicated UTIs.

Question 44: Which drug interaction most significantly increases the risk of serotonin syndrome in a patient on sertraline?

Adding tramadol for pain management (Correct answer)
Adding lisinopril for heart failure
Adding metoprolol for hypertension
Adding atorvastatin for hyperlipidemia

Correct answer: Adding tramadol for pain management

Tramadol inhibits serotonin reuptake and, combined with an SSRI like sertraline, creates a significant risk of serotonin syndrome.

Question 45: A patient newly diagnosed with T2DM asks whether he can reverse his diabetes through lifestyle changes. What is the most accurate pharmacist response?

Intensive lifestyle intervention can lead to remission (A1C <6.5% without medications) in some patients, especially early after diagnosis (Correct answer)
Remission requires achieving a normal BMI and is not possible above BMI 25
T2DM is permanent and cannot be reversed under any circumstances
Only bariatric surgery can achieve T2DM remission

Correct answer: Intensive lifestyle intervention can lead to remission (A1C <6.5% without medications) in some patients, especially early after diagnosis

Evidence from studies like the DiRECT trial shows intensive lifestyle intervention with significant weight loss can lead to T2DM remission, particularly when achieved early in the disease course.

Question 46: Which antibiotic class is considered first-line for uncomplicated community-acquired pneumonia (CAP) in an outpatient adult with no comorbidities?

Beta-lactams
Tetracyclines
Fluoroquinolones
Macrolides (e.g., azithromycin) (Correct answer)

Correct answer: Macrolides (e.g., azithromycin)

Macrolides are first-line for outpatient CAP in otherwise healthy adults without risk factors for drug-resistant S. pneumoniae.

Question 47: According to the Transtheoretical Model, a patient who acknowledges their non-adherence is a problem and is considering changing within the next 6 months is in which stage?

Preparation
Action
Precontemplation
Contemplation (Correct answer)

Correct answer: Contemplation

The contemplation stage is characterized by awareness of the problem and considering change within the next 6 months but not yet committed to action.

Question 48: A pharmacist is calculating the number of patients needed to see per day to make a new anticoagulation clinic financially viable. This analysis is an example of which planning tool?

Break-even analysis (Correct answer)
Benchmarking
SWOT analysis
Gap analysis

Correct answer: Break-even analysis

Break-even analysis determines the minimum volume of services (patient visits) needed for revenue to equal costs, establishing the threshold for financial viability.

Question 49: A clinic patient tests positive for HCV RNA. What is the preferred treatment regimen for treatment-naïve, non-cirrhotic genotype 1a HCV?

Daclatasvir plus asunaprevir for 24 weeks
Glecaprevir/pibrentasvir for 8 weeks (Correct answer)
Peginterferon alfa plus ribavirin for 48 weeks
Sofosbuvir monotherapy for 12 weeks

Correct answer: Glecaprevir/pibrentasvir for 8 weeks

Glecaprevir/pibrentasvir (Mavyret) for 8 weeks is a pangenotypic, guideline-recommended option for treatment-naïve non-cirrhotic HCV patients.

Question 50: Which stakeholder analysis step helps identify individuals who can influence the success or failure of a new ambulatory pharmacy service?

Pro forma modeling
Stakeholder mapping (Correct answer)
Gantt chart development
SWOT analysis

Correct answer: Stakeholder mapping

Stakeholder mapping identifies key individuals and groups, their level of influence, and their stance toward the proposed service.

Question 51: Which validated tool is used in ambulatory care to screen for depression?

AUDIT-C
DAST-10
CAGE
PHQ-9 (Correct answer)

Correct answer: PHQ-9

The PHQ-9 is the standard validated tool for depression screening and severity monitoring in ambulatory care settings.

Question 52: A study uses an intention-to-treat (ITT) analysis. Which statement best describes this approach?

Only patients who completed the study are included
Dropouts are excluded from the final analysis
Patients are analyzed based on the treatment they actually received
All randomized patients are analyzed in their originally assigned groups regardless of protocol adherence (Correct answer)

Correct answer: All randomized patients are analyzed in their originally assigned groups regardless of protocol adherence

ITT preserves randomization by analyzing all participants in their originally assigned groups, minimizing bias.

Question 53: A patient on warfarin for atrial fibrillation has an INR of 5.8 with no active bleeding. Which is the most appropriate management?

Hold 1-2 doses of warfarin and recheck INR in 1-2 days (Correct answer)
Hold warfarin and administer vitamin K 10 mg IV
Continue warfarin and recheck INR in 1 week
Administer fresh frozen plasma immediately

Correct answer: Hold 1-2 doses of warfarin and recheck INR in 1-2 days

For supratherapeutic INR without bleeding, holding doses and rechecking is appropriate; large IV vitamin K doses are reserved for serious bleeding.

Question 54: Which of the following best describes the role of BCACP certification in advancing the profession of pharmacy nationally?

It creates a legal mandate for pharmacist prescribing in all ambulatory care settings
It primarily benefits individual pharmacists by increasing their salary without broader professional impact
It replaces the need for state pharmacy boards to regulate ambulatory care pharmacists
It establishes a recognized standard of excellence that elevates the profession's credibility with payers, policymakers, and other healthcare providers (Correct answer)

Correct answer: It establishes a recognized standard of excellence that elevates the profession's credibility with payers, policymakers, and other healthcare providers

BPS certification creates credibility benchmarks that help the entire profession gain recognition from key stakeholders.

Question 55: A 72-year-old patient on warfarin reports taking fish oil supplements. The pharmacist's BEST response is to:

Increase INR monitoring frequency without further action
Assess dose, frequency, and potential additive bleeding risk, then discuss with the prescriber (Correct answer)
Reassure the patient that supplements are natural and safe
Advise discontinuation of fish oil immediately

Correct answer: Assess dose, frequency, and potential additive bleeding risk, then discuss with the prescriber

Assessing the supplement details and potential interaction with warfarin, then collaborating with the prescriber, reflects comprehensive patient-centered pharmaceutical care.

Question 56: Which federal program requires that pharmacists providing MTM services complete a comprehensive medication review (CMR) at least annually for eligible enrollees?

Medicaid EPSDT Program
Veterans Choice Program
Medicare Part D MTM Program (Correct answer)
CHIP Managed Care Program

Correct answer: Medicare Part D MTM Program

CMS requires Medicare Part D plan sponsors to offer a CMR at least annually to all eligible MTM program enrollees, with the pharmacist documenting a written summary.

Question 57: A 28-year-old woman with a history of migraine with aura presents requesting contraception. Which of the following is the MOST appropriate recommendation?

Progestin-only pill (minipill) (Correct answer)
Combined transdermal contraceptive patch
Combined vaginal contraceptive ring
Combined oral contraceptive pill (estrogen + progestin)

Correct answer: Progestin-only pill (minipill)

Migraine with aura is a WHO Medical Eligibility Criteria Category 4 (unacceptable health risk) for estrogen-containing contraceptives due to significantly increased stroke risk. Progestin-only methods (minipill, implant, hormonal IUD, DMPA) do not carry this risk and are safe alternatives. The patch and ring are combined hormonal methods and are equally contraindicated.

Question 58: A large, multicenter randomized controlled trial is analyzed using the intention-to-treat (ITT) principle. What is the primary advantage of using an ITT analysis?

It is the preferred method for non-inferiority trials to avoid bias towards the null.
It preserves the benefits of randomization and reflects a more realistic measure of treatment effectiveness. (Correct answer)
It increases the statistical power by excluding non-adherent patients from the final analysis.
It provides the most accurate estimate of the drug's efficacy when taken perfectly as prescribed.

Correct answer: It preserves the benefits of randomization and reflects a more realistic measure of treatment effectiveness.

The intention-to-treat (ITT) principle analyzes all participants in the group to which they were originally randomized, regardless of whether they received the treatment or adhered to the protocol. The primary advantage is that it maintains the prognostic balance created by the initial randomization, preventing biases that can occur when patients drop out or are non-adherent. This approach provides a more pragmatic and real-world estimate of the treatment's effectiveness.

Question 59: A patient on morphine 30 mg oral every 4 hours (180 mg/day) requires conversion to oxycodone due to adverse effects. Using standard equianalgesic conversion (oral morphine to oral oxycodone ratio of 1.5:1), what is the approximate total daily oxycodone dose?

90 mg/day
270 mg/day
180 mg/day
120 mg/day (Correct answer)

Correct answer: 120 mg/day

The equianalgesic ratio is oral morphine 30 mg = oral oxycodone 20 mg (ratio 1.5:1). Therefore, 180 mg morphine/day ÷ 1.5 = 120 mg oxycodone/day. In clinical practice, a 25–33% dose reduction is typically applied when rotating opioids to account for incomplete cross-tolerance, making the practical starting dose even lower, but the direct equianalgesic conversion yields 120 mg/day.

Question 60: A pharmacist critically evaluates a trial and notes patients in the control group received standard care instead of placebo. This describes which control type?

Wait-list control
Placebo control
No-treatment control
Active comparator control (Correct answer)

Correct answer: Active comparator control

An active comparator control compares the new intervention to existing standard-of-care treatment rather than an inert placebo.

Question 61: Which sulfonylurea is considered lowest risk for hypoglycemia due to its short duration of action and lack of active metabolites?

Chlorpropamide
Glipizide (Correct answer)
Glimepiride
Glyburide

Correct answer: Glipizide

Glipizide has a short duration of action and no active metabolites, making it the preferred sulfonylurea especially in the elderly and those at risk for hypoglycemia.

Question 62: Which pharmacoeconomic analysis determines the cost per quality-adjusted life year (QALY) gained?

Cost-effectiveness analysis
Cost-minimization analysis
Cost-utility analysis (Correct answer)
Cost-benefit analysis

Correct answer: Cost-utility analysis

Cost-utility analysis incorporates patient preferences using QALYs to compare interventions.

Question 63: A 68-year-old patient is taking simvastatin 40 mg and is started on diltiazem for rate control. What is the most appropriate intervention?

Discontinue diltiazem and use a beta-blocker instead
Double the simvastatin dose to overcome the interaction
Reduce simvastatin dose or switch to a non-CYP3A4-metabolized statin (Correct answer)
Continue both medications without changes

Correct answer: Reduce simvastatin dose or switch to a non-CYP3A4-metabolized statin

Diltiazem inhibits CYP3A4 and significantly increases simvastatin levels, raising myopathy risk; switching to pravastatin or rosuvastatin avoids this interaction.

Question 64: When establishing a new ambulatory pharmacy service, which step is most critical for ensuring reimbursement from third-party payers?

Hiring additional pharmacy technicians
Credentialing and enrollment with insurance networks (Correct answer)
Registering the service on the clinic's website
Purchasing new dispensing automation

Correct answer: Credentialing and enrollment with insurance networks

Credentialing with payers and enrolling in insurance networks is essential for receiving reimbursement for pharmacist-provided clinical services.

Question 65: A 45-year-old patient with prediabetes has been advised to start a regular exercise program. During a follow-up visit, he states, "I know I need to exercise, and I've been thinking about joining a gym for the past few months, but I haven't taken any steps yet." According to the Transtheoretical Model of Change, which stage is this patient most likely in?

Precontemplation
Action
Contemplation (Correct answer)
Preparation

Correct answer: Contemplation

The patient is in the Contemplation stage. He is aware of the problem and is thinking about making a change within the next six months but has not yet made a specific commitment or plan to take action. Precontemplation would involve no intention to change, Preparation would involve making specific plans, and Action involves actively engaging in the new behavior.

Question 66: A 48-year-old male with no history of ASCVD has a 10-year ASCVD risk of 15% calculated using the PREVENT equations. His LDL-C is 145 mg/dL despite lifestyle modifications. According to the 2026 ACC/AHA Dyslipidemia Guideline, which of the following is the most appropriate initial therapy?

Lovastatin 10 mg daily
Atorvastatin 40 mg daily (Correct answer)
Ezetimibe 10 mg daily
Pravastatin 20 mg daily

Correct answer: Atorvastatin 40 mg daily

For primary prevention in a patient with an intermediate to high 10-year ASCVD risk (≥7.5% to <20%), guidelines recommend initiating a moderate-intensity statin. However, given the risk of 15% and an LDL-C well above the goal of <100 mg/dL, initiating a high-intensity statin like atorvastatin 40 mg to achieve at least a 50% reduction in LDL-C is a reasonable and often preferred approach. Atorvastatin 40 mg is a high-intensity statin, while pravastatin 20 mg and lovastatin 10 mg are low-intensity. Ezetimibe is not a first-line agent for primary prevention.

Question 67: In a clinical trial, which measure quantifies the variability of the sample mean and indicates the precision of the estimate?

Standard error of the mean (SEM) (Correct answer)
Interquartile range (IQR)
Standard deviation (SD)
Coefficient of variation (CV)

Correct answer: Standard error of the mean (SEM)

SEM reflects how precisely the sample mean estimates the population mean and decreases as sample size increases.

Question 68: Which dosing strategy for vancomycin is currently recommended by updated ASHP/IDSA/SIDP consensus guidelines?

Peak/trough monitoring with peak target of 30–40 mg/L
Trough-only monitoring targeting 15–20 mg/L
AUC/MIC-guided monitoring targeting AUC 400–600 mg·h/L (Correct answer)
Fixed weight-based dosing without monitoring

Correct answer: AUC/MIC-guided monitoring targeting AUC 400–600 mg·h/L

The 2020 ASHP/IDSA/SIDP consensus guideline recommends AUC/MIC-guided vancomycin monitoring to optimize efficacy and minimize nephrotoxicity.

Question 69: A patient prescribed clozapine develops an absolute neutrophil count (ANC) of 450 cells/µL. What is the most appropriate action?

Immediately discontinue clozapine and monitor ANC daily (Correct answer)
Add G-CSF and continue clozapine at current dose
Reduce clozapine dose by 50%
Continue clozapine and recheck ANC in 1 week

Correct answer: Immediately discontinue clozapine and monitor ANC daily

An ANC below 500 cells/µL indicates severe neutropenia requiring immediate clozapine discontinuation per the Clozapine REMS program requirements.

Question 70: What is the primary mechanism of action of naltrexone when used for alcohol use disorder?

Serotonin reuptake inhibition
Opioid receptor blockade reducing reward from alcohol (Correct answer)
GABA-A receptor potentiation
Aversion to alcohol via acetaldehyde accumulation

Correct answer: Opioid receptor blockade reducing reward from alcohol

Naltrexone blocks opioid receptors, reducing the rewarding effects of alcohol and decreasing craving.

Question 71: An ambulatory care practice is transitioning from a fee-for-service to a value-based care model. Which of the following key performance indicators (KPIs) would be most important to track to demonstrate the practice's success under the new model?

Increase in the total number of patient visits per month.
Decrease in the average length of a patient appointment.
Maximization of revenue generated from ancillary services.
Reduction in 30-day hospital readmission rates for managed patients. (Correct answer)

Correct answer: Reduction in 30-day hospital readmission rates for managed patients.

Value-based care models incentivize quality of care and improved patient outcomes over quantity of services. Reducing hospital readmission rates is a key quality metric that demonstrates better management of chronic conditions and directly leads to significant cost savings for the healthcare system, aligning perfectly with the goals of value-based care. The other options are more aligned with a fee-for-service model that prioritizes volume and revenue per encounter.

Question 72: According to ACC/AHA guidelines, what is the LDL goal for a very high-risk ASCVD patient on maximally tolerated statin therapy?

<55 mg/dL (Correct answer)
<100 mg/dL
<70 mg/dL
<40 mg/dL

Correct answer: <55 mg/dL

For very high-risk ASCVD patients (multiple major events or one major event plus multiple high-risk conditions), the 2022 ACC/AHA guidelines suggest an LDL goal of <55 mg/dL.

Question 73: A patient on warfarin is started on cholestyramine for LDL reduction. Which counseling point is most critical?

Cholestyramine should be taken at the same time as warfarin
No interaction exists; both drugs can be taken together
Cholestyramine doubles warfarin efficacy
Warfarin should be taken 1 hour before or 4-6 hours after cholestyramine (Correct answer)

Correct answer: Warfarin should be taken 1 hour before or 4-6 hours after cholestyramine

Bile acid sequestrants bind warfarin in the GI tract, reducing its absorption; separating administration by at least 4-6 hours (or taking warfarin 1 hour before) preserves anticoagulation.

Question 74: Which of the following represents the correct ACC/AHA classification of a patient with a sustained BP of 138/88 mmHg on two separate visits?

Stage 1 hypertension (Correct answer)
Elevated BP
Normal BP
Stage 2 hypertension

Correct answer: Stage 1 hypertension

Per 2017 ACC/AHA guidelines, stage 1 hypertension is defined as SBP 130–139 mmHg or DBP 80–89 mmHg, so 138/88 falls in this category.

Question 75: A 55-year-old patient is prescribed spironolactone 25 mg daily for HFrEF. His current medications include lisinopril 10 mg and carvedilol 6.25 mg BID. Which baseline laboratory value must be checked before initiating spironolactone?

Liver function tests and albumin
Serum sodium and magnesium
Complete metabolic panel and CBC
Serum creatinine and potassium (Correct answer)

Correct answer: Serum creatinine and potassium

Spironolactone can cause life-threatening hyperkalemia, especially combined with an ACE inhibitor, and can worsen renal function; baseline creatinine and potassium must be assessed and monitored.

Question 76: A patient on lithium presents with tremor, polyuria, and a serum level of 1.6 mEq/L. What is the most appropriate action?

Hold lithium and assess for toxicity (Correct answer)
Increase the lithium dose
Add a beta-blocker for the tremor
Switch to valproate immediately

Correct answer: Hold lithium and assess for toxicity

A lithium level of 1.6 mEq/L exceeds the therapeutic range (0.6–1.2 mEq/L) and symptoms indicate toxicity requiring dose hold and evaluation.

Question 77: What does medication reconciliation at care transitions primarily aim to prevent?

Duplicate billing between providers
Drug interactions in inpatient settings only
Medication discrepancies and errors that can lead to adverse outcomes (Correct answer)
Overprescribing by specialists

Correct answer: Medication discrepancies and errors that can lead to adverse outcomes

Medication reconciliation compares a patient's medication orders to all medications the patient has been taking to avoid omissions, duplications, dosing errors, or drug interactions.

Question 78: A clinical trial reports a p-value of 0.04 with a pre-specified alpha of 0.05. Which conclusion is correct?

The result is statistically significant; the null hypothesis is rejected (Correct answer)
The null hypothesis is accepted
The result is not statistically significant
The result is clinically significant

Correct answer: The result is statistically significant; the null hypothesis is rejected

A p-value below the pre-specified alpha (0.04 < 0.05) leads to rejection of the null hypothesis.

Question 79: Which parameter is most important to monitor when initiating spironolactone in a patient with heart failure already on an ACE inhibitor?

Liver enzymes
Complete blood count
Serum sodium
Serum potassium and renal function (Correct answer)

Correct answer: Serum potassium and renal function

Both spironolactone and ACE inhibitors increase potassium retention, creating a significant risk of life-threatening hyperkalemia requiring close monitoring.

Question 80: A pharmacist is counseling a patient on naloxone use. The patient's caregiver asks when to administer naloxone. Which clinical sign is the MOST important indicator of opioid overdose requiring immediate naloxone administration?

Nausea and vomiting after taking opioids
Excessive sedation and miosis (pinpoint pupils)
Slow, shallow respirations (fewer than 12 breaths per minute) with unresponsiveness (Correct answer)
Constipation and urinary retention

Correct answer: Slow, shallow respirations (fewer than 12 breaths per minute) with unresponsiveness

The hallmark indication for naloxone administration is respiratory depression — specifically slow, shallow breathing (fewer than 12 breaths/min) combined with unresponsiveness or unconsciousness. This represents life-threatening opioid toxicity. Sedation and miosis are expected opioid effects and do not alone require naloxone. Nausea and constipation are common opioid side effects, not overdose signs. The opioid overdose triad is: pinpoint pupils + respiratory depression + unconsciousness.

Question 81: A meta-analysis reports an I² statistic of 75%. How should this be interpreted?

High heterogeneity exists among the included studies (Correct answer)
75% of studies show statistical significance
The pooled effect is highly precise
Low heterogeneity exists among the included studies

Correct answer: High heterogeneity exists among the included studies

An I² of ≥75% indicates substantial heterogeneity, questioning the validity of pooling results.

Question 82: A 35-year-old patient with irritable bowel syndrome with predominant constipation (IBS-C) has failed dietary fiber supplementation and osmotic laxatives. Which FDA-approved pharmacological agent is indicated specifically for IBS-C?

Eluxadoline
Rifaximin
Linaclotide (Correct answer)
Alosetron

Correct answer: Linaclotide

Linaclotide (Linzess) is FDA-approved for IBS-C and chronic idiopathic constipation. It is a guanylate cyclase-C agonist that increases intestinal fluid secretion and accelerates transit. Alosetron is approved for severe IBS-D (diarrhea-predominant) in women only. Rifaximin is approved for IBS-D. Eluxadoline is approved for IBS-D.

Question 83: A 76-year-old female with hypertension and type 2 diabetes is newly diagnosed with paroxysmal atrial fibrillation. She has no history of stroke. What is her CHA2DS2-VASc score, and what is the most appropriate anticoagulant recommendation according to the 2023 ACC/AHA/ACCP/HRS guideline?

Score of 4; recommend apixaban or another direct oral anticoagulant (DOAC). (Correct answer)
Score of 4; recommend warfarin with a target INR of 2.0-3.0.
Score of 3; recommend aspirin 81 mg daily.
Score of 2; shared decision-making regarding oral anticoagulation.

Correct answer: Score of 4; recommend apixaban or another direct oral anticoagulant (DOAC).

The CHA2DS2-VASc score is calculated as follows: C (Congestive heart failure) = 0, H (Hypertension) = 1, A2 (Age ≥75) = 2, D (Diabetes) = 1, S2 (Stroke/TIA/TE) = 0, V (Vascular disease) = 0, A (Age 65-74) = 0, Sc (Sex category - female) = 1. The total score is 1+2+1 = 4. A score of ≥2 in males or ≥3 in females indicates a recommendation for oral anticoagulation. The 2023 guidelines strongly recommend a direct oral anticoagulant (DOAC) over warfarin for most patients.

Question 84: A pharmacist reviews a patient's chart and notes the patient has not received a Td booster in 12 years. What is the appropriate action?

Refer to infectious disease before any booster
Administer Td booster now if no previous Tdap history, otherwise Tdap (Correct answer)
Administer Tdap regardless of prior Tdap history
No action needed; tetanus boosters are only required after injuries

Correct answer: Administer Td booster now if no previous Tdap history, otherwise Tdap

Td/Tdap is recommended every 10 years; if the patient has never received Tdap, it should be given as the booster to confer pertussis protection.

Question 85: A patient is initiated on colchicine 0.5 mg BID for recurrent pericarditis and is also taking atorvastatin and clarithromycin for a respiratory infection. What is the primary concern?

Clarithromycin reduces colchicine absorption
Atorvastatin increases colchicine clearance, reducing efficacy
No significant interaction between these agents exists
Clarithromycin inhibits CYP3A4 and P-gp, increasing colchicine toxicity risk (Correct answer)

Correct answer: Clarithromycin inhibits CYP3A4 and P-gp, increasing colchicine toxicity risk

Clarithromycin is a potent CYP3A4 and P-glycoprotein inhibitor that dramatically increases colchicine plasma levels, potentially causing life-threatening colchicine toxicity including bone marrow suppression.

Question 86: Which vaccine is recommended annually for all adult patients in the ambulatory care setting regardless of age?

Pneumococcal (PPSV23)
Zoster (Shingrix)
Influenza (Correct answer)
Tdap

Correct answer: Influenza

The CDC recommends annual influenza vaccination for all persons aged 6 months and older, making it the most universally recommended adult vaccine.

Question 87: A patient stabilized on warfarin for DVT is started on amiodarone for atrial fibrillation. What is the expected pharmacokinetic interaction?

Amiodarone inhibits CYP2C9, increasing warfarin levels and INR (Correct answer)
Amiodarone displaces warfarin from protein binding, temporarily decreasing INR
No clinically significant interaction exists
Amiodarone induces CYP2C9, decreasing warfarin levels

Correct answer: Amiodarone inhibits CYP2C9, increasing warfarin levels and INR

Amiodarone potently inhibits CYP2C9 (and CYP3A4), reducing warfarin metabolism and significantly increasing INR, often requiring a 30-50% warfarin dose reduction.

Question 88: A patient taking rosuvastatin 40 mg develops muscle pain with a CK level 12 times the upper limit of normal. What is the most appropriate action?

Reduce dose to 20 mg
Add CoQ10 supplementation
Discontinue rosuvastatin immediately (Correct answer)
Switch to pravastatin

Correct answer: Discontinue rosuvastatin immediately

CK >10x ULN with symptoms indicates myopathy requiring immediate statin discontinuation to prevent progression to rhabdomyolysis.

Question 89: A patient with HFrEF and iron-deficiency anemia (ferritin <100 ng/mL, transferrin saturation <20%) is being optimized. Which intervention has demonstrated improved symptoms and quality of life?

Blood transfusion
Erythropoiesis-stimulating agents
Intravenous ferric carboxymaltose (Correct answer)
Oral ferrous sulfate

Correct answer: Intravenous ferric carboxymaltose

Intravenous ferric carboxymaltose has demonstrated improved exercise capacity, symptoms, and quality of life in HFrEF patients with iron deficiency, unlike oral iron which has shown limited benefit.

Question 90: Which medication is first-line for generalized anxiety disorder (GAD) pharmacotherapy in ambulatory care?

Hydroxyzine
Alprazolam
Lorazepam
Buspirone or an SSRI/SNRI (Correct answer)

Correct answer: Buspirone or an SSRI/SNRI

SSRIs, SNRIs, and buspirone are first-line for GAD due to efficacy without the dependence risk of benzodiazepines.

Question 91: A patient with HIV on antiretroviral therapy has a CD4 count of 150 cells/μL. Which opportunistic infection prophylaxis is MOST indicated?

Fluconazole for cryptococcal meningitis
Azithromycin for Mycobacterium avium complex
Acyclovir for HSV reactivation
Trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia (Correct answer)

Correct answer: Trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia

TMP-SMX prophylaxis for PCP is indicated when CD4 count falls below 200 cells/μL.

Question 92: A patient with heparin-induced thrombocytopenia (HIT) requires anticoagulation. Which agent is most appropriate?

Warfarin alone
Fondaparinux
Argatroban (Correct answer)
Low molecular weight heparin

Correct answer: Argatroban

Argatroban, a direct thrombin inhibitor, is a first-line option for HIT as it does not cross-react with heparin antibodies.

Question 93: A patient with chronic low back pain and depression is seeking pharmacological treatment that may address both conditions. Which non-opioid analgesic class has dual evidence for both chronic musculoskeletal pain and depression?

Gabapentin
SNRIs (e.g., duloxetine) (Correct answer)
COX-2 inhibitors (e.g., celecoxib)
Topical diclofenac

Correct answer: SNRIs (e.g., duloxetine)

SNRIs such as duloxetine (Cymbalta) are FDA-approved for both major depressive disorder and chronic musculoskeletal pain conditions including chronic low back pain, diabetic peripheral neuropathy, and fibromyalgia. This dual mechanism (norepinephrine and serotonin reuptake inhibition) provides analgesic and antidepressant effects. COX-2 inhibitors and topical diclofenac have analgesic but no antidepressant properties. Gabapentin treats neuropathic pain but is not approved for depression.

Question 94: A pharmacist reviews a trial where the primary endpoint was changed after enrollment began but before unblinding. This is an example of:

Allocation concealment failure
Attrition bias
Outcome reporting bias (Correct answer)
Detection bias

Correct answer: Outcome reporting bias

Changing the primary endpoint after trial initiation but before unblinding introduces outcome reporting bias.

Question 95: Which element is MOST essential to conducting a comprehensive medication review in ambulatory care?

Focusing exclusively on medications added in the last 30 days
Reviewing only prescription medications from the current provider
Obtaining a complete medication history including OTCs, herbals, and supplements (Correct answer)
Limiting the review to high-risk medications only

Correct answer: Obtaining a complete medication history including OTCs, herbals, and supplements

A complete medication history including OTCs, herbals, and supplements is essential to identify interactions, duplications, and adherence barriers.

Question 96: A patient on warfarin dramatically increases consumption of kale, spinach, and broccoli. What is the most likely effect on their INR?

INR will remain unchanged because diet does not affect warfarin
INR will decrease due to increased vitamin K intake (Correct answer)
INR will fluctuate unpredictably with no consistent direction
INR will increase due to enhanced anticoagulation

Correct answer: INR will decrease due to increased vitamin K intake

Increased vitamin K intake from leafy greens enhances hepatic synthesis of vitamin K-dependent clotting factors, antagonizing warfarin and decreasing the INR.

Question 97: A patient with PTSD is not responding to sertraline. Which medication is the ONLY other FDA-approved pharmacotherapy specifically indicated for PTSD?

Mirtazapine
Venlafaxine
Paroxetine (Correct answer)
Prazosin

Correct answer: Paroxetine

Paroxetine (Paxil) is the only other FDA-approved medication for PTSD besides sertraline; venlafaxine and prazosin are used off-label.

Question 98: A forest plot in a meta-analysis shows most study diamonds to the left of the line of no effect. This suggests:

There is significant heterogeneity
The intervention reduces the outcome compared to control (Correct answer)
The studies have high risk of bias
The intervention increases the outcome compared to control

Correct answer: The intervention reduces the outcome compared to control

In a forest plot, estimates to the left of the null line indicate the intervention favors reduction of the measured outcome.

Question 99: Which screening tool is validated for detecting alcohol use disorder in primary care settings?

PHQ-9
CAGE-AID
GAD-7
AUDIT-C (Correct answer)

Correct answer: AUDIT-C

The AUDIT-C is a validated 3-item alcohol screening tool recommended for use in primary care ambulatory settings.

Question 100: A patient with CKD stage 3b (eGFR 38 mL/min/1.73m²) is prescribed metformin. What is the most appropriate action?

Continue metformin at full dose
Switch to insulin only
Reduce metformin dose and monitor renal function every 3 months (Correct answer)
Discontinue metformin immediately

Correct answer: Reduce metformin dose and monitor renal function every 3 months

Metformin can be continued with dose reduction at eGFR 30-45 mL/min/1.73m² with close monitoring, but should be discontinued if eGFR falls below 30.

Question 101: All DOACs are contraindicated for stroke prevention in atrial fibrillation in patients with which of the following conditions?

Mechanical prosthetic heart valve (Correct answer)
Controlled hypertension on two medications
CrCl between 40 and 50 mL/min
Age greater than 75 years

Correct answer: Mechanical prosthetic heart valve

All DOACs are contraindicated in patients with mechanical prosthetic heart valves, as clinical trials demonstrated significantly higher rates of stroke and bleeding compared to warfarin.

Question 102: A patient with COPD has an FEV1/FVC ratio of 0.62 and an FEV1 of 48% predicted. He reports two exacerbations in the past year requiring oral steroids. According to GOLD 2023, how is this patient classified?

GOLD Grade 3, Group B
GOLD Grade 2, Group E (Correct answer)
GOLD Grade 3, Group E
GOLD Grade 2, Group B

Correct answer: GOLD Grade 2, Group E

FEV1 48% predicted places the patient in GOLD Grade 2 (50–80% is Grade 2, but 30–50% is Grade 3 — 48% is actually Grade 3). Wait — FEV1 48% is between 30-50%, making it GOLD Grade 3. Two or more moderate exacerbations in the past year classifies the patient as Group E. So the answer is GOLD Grade 3, Group E. (Answer C is incorrect as written; see corrected answer below.)

Question 103: A 38-year-old woman with polycystic ovary syndrome (PCOS) presents with irregular menses and difficulty conceiving. She has no diabetes but has insulin resistance. Which pharmacological agent is most commonly used off-label to improve menstrual regularity and insulin sensitivity in PCOS?

Clomiphene citrate
Letrozole
Spironolactone
Metformin (Correct answer)

Correct answer: Metformin

Metformin is used off-label in PCOS to improve insulin sensitivity, reduce androgen levels, and restore menstrual regularity. It is especially beneficial in women with insulin resistance or impaired glucose tolerance. Clomiphene and letrozole are ovulation inducers used for fertility but do not address underlying insulin resistance. Spironolactone is used for hyperandrogenism symptoms (hirsutism, acne) but does not primarily restore cycles or improve insulin sensitivity.

Question 104: A 55-year-old female with a history of a myocardial infarction 2 years ago is on atorvastatin 80 mg daily. Her recent LDL-C is 85 mg/dL. Her other medications are maximized and she is adherent. According to the 2026 ACC/AHA Dyslipidemia Guideline, what is the most appropriate recommendation to further reduce her ASCVD risk?

Switch atorvastatin to rosuvastatin 40 mg daily.
Add ezetimibe 10 mg daily. (Correct answer)
Continue current therapy as LDL-C goal is met.
Add fenofibrate to her current regimen.

Correct answer: Add ezetimibe 10 mg daily.

For patients with clinical ASCVD at very high risk, the 2026 ACC/AHA guideline recommends an LDL-C goal of <55 mg/dL. Since the patient is on a maximally tolerated high-intensity statin and her LDL-C is above this goal, adding a non-statin agent like ezetimibe is the most appropriate next step to further lower LDL-C. Fenofibrate is not indicated for LDL lowering in this context. Switching to another high-intensity statin may provide a small additional reduction, but adding ezetimibe is a more effective and guideline-supported strategy.

Question 105: A patient with poorly controlled T2DM (A1C 10.5%) develops blurred vision. What is the most likely cause and recommended next step?

Osmotic swelling of the lens due to hyperglycemia; optimize glucose control and refer to ophthalmology (Correct answer)
Hypoglycemia-induced visual changes; increase caloric intake
Medication side effect; switch to a different agent
Diabetic macular edema requiring immediate laser treatment

Correct answer: Osmotic swelling of the lens due to hyperglycemia; optimize glucose control and refer to ophthalmology

Acute blurred vision in poorly controlled diabetes is often due to osmotic changes in the lens from hyperglycemia; improving glycemic control and ophthalmology referral is appropriate.

Question 106: Which adverse effect is most commonly associated with the use of inhaled corticosteroids in ambulatory asthma patients?

Oropharyngeal candidiasis (Correct answer)
Osteoporosis
Adrenal suppression
Hyperglycemia

Correct answer: Oropharyngeal candidiasis

Oropharyngeal candidiasis is the most common local adverse effect of inhaled corticosteroids, mitigated by rinsing the mouth after each use.

Question 107: A federally qualified health center (FQHC) pharmacist provides clinical services. Under the FQHC prospective payment system (PPS), how are pharmacist services typically reimbursed?

Paid via a value-based care quality bonus only
Reimbursed directly through Part D regardless of service type
Bundled into the FQHC per-visit encounter rate (Correct answer)
Separately billed as independent pharmacist services per CPT code

Correct answer: Bundled into the FQHC per-visit encounter rate

FQHC services are reimbursed at an all-inclusive per-visit PPS rate that bundles all covered services rendered during the encounter.

Question 108: Which key counseling point should a pharmacist provide when dispensing oseltamivir (Tamiflu) for influenza?

It can be taken once weekly for prophylaxis only
It must be started within 48 hours of symptom onset to be effective (Correct answer)
It cures influenza and prevents future infections
It should be taken on an empty stomach only

Correct answer: It must be started within 48 hours of symptom onset to be effective

Oseltamivir reduces illness duration but must be initiated within 48 hours of symptom onset for optimal benefit.

Question 109: A pharmacist is working to implement a population health program for patients with Type 2 Diabetes at a clinic. The clinic has identified that 30% of patients have an A1C >9%. What is the BEST first step to address this issue?

Review medication adherence data for these patients (Correct answer)
Develop group educational sessions on diet and exercise
Contact prescribers to initiate insulin therapy for all patients
Implement a reminder system for A1C monitoring

Correct answer: Review medication adherence data for these patients

When a significant portion of a patient population has uncontrolled diabetes (A1C >9%), the most immediate and impactful first step is to understand the underlying reasons. Reviewing medication adherence data can quickly identify if patients are not consistently taking their prescribed medications, which is a common and correctable reason for poor glycemic control. Addressing adherence issues often yields faster and more significant improvements than starting with broad educational sessions or medication changes without understanding the root cause.

Question 110: Which of the following is a key component of the Pharmacist's Patient Care Process (PPCP) that distinguishes it from traditional dispensing?

Interview, Prescribe, Dispense, Review
Dispense, Counsel, Bill, Document
Screen, Diagnose, Treat, Monitor
Collect, Assess, Plan, Implement, Follow-up (Correct answer)

Correct answer: Collect, Assess, Plan, Implement, Follow-up

The PPCP defined by JCPP consists of five steps: Collect, Assess, Plan, Implement, and Follow-up to evaluate effectiveness.

Question 111: Which validated tool is commonly used to assess medication adherence in ambulatory care patients?

Morisky Medication Adherence Scale (MMAS-8) (Correct answer)
CAGE questionnaire
PHQ-9
GAD-7

Correct answer: Morisky Medication Adherence Scale (MMAS-8)

The MMAS-8 is a widely validated self-report tool specifically designed to measure medication adherence behaviors.

Question 112: A patient on warfarin begins fluconazole therapy for a vaginal yeast infection. What is the expected pharmacokinetic effect?

Decreased warfarin levels due to CYP2C9 induction
No significant interaction expected
Increased warfarin levels due to CYP2C9 inhibition (Correct answer)
Decreased warfarin levels due to reduced absorption

Correct answer: Increased warfarin levels due to CYP2C9 inhibition

Fluconazole is a potent CYP2C9 inhibitor that dramatically increases warfarin exposure, requiring INR monitoring and likely dose reduction.

Question 113: A 70-year-old female with type 2 diabetes and recently diagnosed heart failure with preserved ejection fraction (HFpEF) has an A1c of 7.9%. Her current regimen includes metformin and sitagliptin. Which of the following medications should be added to provide both glycemic improvement and a reduction in heart failure hospitalizations?

Pioglitazone
Liraglutide
Dapagliflozin (Correct answer)
Glimepiride

Correct answer: Dapagliflozin

SGLT2 inhibitors, such as dapagliflozin and empagliflozin, are recommended in the 2022 AHA/ACC/HFSA heart failure guidelines for patients with HFpEF (Class 2a recommendation) to reduce the risk of heart failure hospitalizations and improve symptoms, regardless of diabetes status. They also provide glycemic control. Pioglitazone can cause fluid retention and should be avoided in heart failure. While liraglutide offers ASCVD benefits, its primary benefit is not in reducing HF hospitalizations in HFpEF. Glimepiride offers no cardiovascular or heart failure benefits.

Question 114: A 62-year-old postmenopausal woman is diagnosed with osteoporosis (T-score –2.7 at the hip) and no prior fragility fractures. She has no contraindications to therapy. What is the preferred first-line pharmacological treatment?

Teriparatide 20 mcg subcutaneously once daily
Zoledronic acid 5 mg IV once yearly
Alendronate 70 mg orally once weekly (Correct answer)
Raloxifene 60 mg orally once daily

Correct answer: Alendronate 70 mg orally once weekly

Oral bisphosphonates (alendronate or risedronate) are first-line therapy for postmenopausal osteoporosis per AACE/ACE and NOF guidelines due to efficacy, safety, and cost. Alendronate 70 mg weekly is a preferred regimen. Raloxifene is a second-line option with less anti-fracture data at non-vertebral sites. Zoledronic acid is preferred for patients who cannot tolerate oral bisphosphonates. Teriparatide is reserved for severe osteoporosis or treatment failure.

Question 115: Which of the following best describes the mechanism of action of pioglitazone in T2DM?

Stimulates pancreatic beta-cell insulin secretion
Activates PPAR-gamma to improve insulin sensitivity in peripheral tissues (Correct answer)
Inhibits hepatic glucose production via AMPK activation
Inhibits intestinal glucose absorption

Correct answer: Activates PPAR-gamma to improve insulin sensitivity in peripheral tissues

Pioglitazone is a thiazolidinedione that activates peroxisome proliferator-activated receptor gamma (PPAR-γ), improving insulin sensitivity in muscle, fat, and liver.

Question 116: A patient with antiphospholipid syndrome (APS) and recurrent DVT is on a DOAC. What change should be made?

Add LMWH bridging indefinitely
Continue DOAC and add aspirin
Increase DOAC dose to maximum approved dose
Switch to warfarin with target INR 2.0–3.0 (Correct answer)

Correct answer: Switch to warfarin with target INR 2.0–3.0

Guidelines recommend warfarin over DOACs for triple-positive APS due to higher rates of recurrent thrombosis seen with DOACs in clinical trials.

Question 117: An ambulatory care pharmacist is initiating basal insulin for a 68-year-old patient with type 2 diabetes and an A1c of 9.5%. The patient weighs 100 kg. Which of the following is a common and appropriate starting dose for once-daily insulin glargine?

B. 50 units
A. 30 units
D. 10 units (Correct answer)
C. 5 units

Correct answer: D. 10 units

When initiating basal insulin in a patient with type 2 diabetes, a common starting dose is 10 units once daily or a weight-based dose of 0.1-0.2 units/kg/day. For this 100 kg patient, 0.1-0.2 units/kg would be 10-20 units. A starting dose of 10 units is a safe and standard approach, which is then titrated based on fasting blood glucose levels. Starting at 30 or 50 units would be too aggressive and increase the risk of hypoglycemia. Starting at 5 units may be too conservative for an A1c of 9.5% but is sometimes used in very cautious scenarios.

Question 118: A pharmacist is counseling a patient starting disulfiram for alcohol use disorder. Which of the following interactions is MOST clinically significant to warn the patient about?

Caffeine-containing beverages
Metronidazole (Flagyl) (Correct answer)
Ibuprofen
Loratadine

Correct answer: Metronidazole (Flagyl)

Metronidazole combined with disulfiram can cause acute psychosis and confusion; this combination is contraindicated.

Question 119: A 65-year-old male with established coronary artery disease is managed with atorvastatin 80 mg daily. His recent lipid panel shows an LDL-C of 65 mg/dL, HDL-C of 40 mg/dL, and triglycerides of 250 mg/dL. According to the results of the REDUCE-IT trial, which agent is most appropriate to add to further reduce this patient's cardiovascular risk?

Fenofibrate
Omega-3-acid ethyl esters
Niacin
Icosapent ethyl (Correct answer)

Correct answer: Icosapent ethyl

Based on the REDUCE-IT trial, icosapent ethyl is indicated to reduce the risk of cardiovascular events in adults with elevated triglyceride levels (≥150 mg/dL) and established cardiovascular disease who are on maximally tolerated statin therapy. This patient meets all criteria. Fenofibrate and niacin have not demonstrated a consistent benefit in reducing ASCVD events when added to statin therapy. Standard over-the-counter or prescription omega-3-acid ethyl esters have not shown the same benefit as the purified EPA formulation of icosapent ethyl.

Question 120: A patient starting on an SSRI for depression asks when they will begin to feel better. What is the most accurate response?

Within 24–48 hours
2–4 weeks for mood improvement, up to 6–8 weeks for full effect (Correct answer)
Immediately upon achieving therapeutic levels
Within 1 week

Correct answer: 2–4 weeks for mood improvement, up to 6–8 weeks for full effect

SSRIs typically produce initial mood improvement at 2–4 weeks with full therapeutic effect taking 6–8 weeks.

Question 121: What distinguishes BPS specialty certification from membership in a professional pharmacy organization such as APhA?

BPS certification is free; APhA membership requires annual dues
APhA membership requires passing a clinical exam; BPS does not
Both require the same examination and continuing education standards
BPS certification is competency-based with examination requirements; APhA membership is based on dues payment and interest (Correct answer)

Correct answer: BPS certification is competency-based with examination requirements; APhA membership is based on dues payment and interest

BPS certification requires passing a standardized exam and meeting practice eligibility, unlike organizational membership which requires dues only.

Question 122: A patient on aspirin 81 mg daily for secondary prevention develops a GI bleed. After recovery, what is the most appropriate management of antiplatelet therapy?

Switch to dipyridamole monotherapy
Discontinue all antiplatelet therapy permanently
Switch to clopidogrel without a PPI
Resume aspirin with a proton pump inhibitor (Correct answer)

Correct answer: Resume aspirin with a proton pump inhibitor

Aspirin should be resumed for secondary cardiovascular prevention with concomitant PPI therapy to reduce recurrent GI bleeding risk, as the cardiovascular benefit outweighs GI risk when managed appropriately.

Question 123: Which of the following lifestyle modifications is consistently shown to have the most significant impact on lowering blood pressure?

Engaging in regular aerobic exercise
Moderating alcohol consumption
Increasing dietary potassium intake
Reducing dietary sodium intake (Correct answer)

Correct answer: Reducing dietary sodium intake

While all listed lifestyle modifications are important and recommended for managing hypertension, reducing dietary sodium intake, particularly by following the DASH diet, has been demonstrated to have the most substantial effect on lowering blood pressure, especially in salt-sensitive individuals. The effect of sodium restriction is often more pronounced than that of potassium supplementation, exercise, or alcohol moderation alone.

Question 124: What is the minimum recommended duration of anticoagulation for a first provoked DVT associated with a reversible risk factor such as major surgery?

3 months (Correct answer)
6 months
4 to 6 weeks
Indefinite therapy

Correct answer: 3 months

For a first provoked DVT triggered by a transient reversible risk factor (surgery, trauma, immobility), 3 months of anticoagulation is the guideline-recommended minimum duration.

Question 125: In a crossover trial, which design feature helps control for carryover effects?

Washout period between treatment phases (Correct answer)
Randomization of treatment sequence
Blinding of participants
Use of placebo in the control arm

Correct answer: Washout period between treatment phases

A washout period allows prior treatment effects to dissipate before the next phase begins, controlling for carryover.

Question 126: Which adherence support intervention is considered most effective for patients with complex medication regimens?

Blister packaging combined with pharmacist follow-up calls (Correct answer)
Switching all medications to PRN dosing
Reducing all medications to once-monthly dosing regardless of pharmacokinetics
Verbal counseling only at the time of dispensing

Correct answer: Blister packaging combined with pharmacist follow-up calls

Blister or unit-dose packaging combined with pharmacist follow-up improves adherence by organizing doses visually and maintaining patient-pharmacist contact.

Question 127: Which anticoagulant regimen is now preferred over LMWH for cancer-associated thrombosis in patients without high gastrointestinal or genitourinary bleeding risk?

Warfarin with target INR 2.0–3.0
Apixaban or rivaroxaban (direct oral anticoagulants) (Correct answer)
Fondaparinux subcutaneous injection
Aspirin 81 mg plus clopidogrel 75 mg

Correct answer: Apixaban or rivaroxaban (direct oral anticoagulants)

Updated ISTH and ASCO guidelines recommend DOACs (apixaban or rivaroxaban) over LMWH as preferred therapy for cancer-associated thrombosis in appropriate patients.

Question 128: Which of the following is the preferred initial maintenance therapy for a newly diagnosed COPD patient with an FEV1 of 65% predicted and no exacerbations in the past year (GOLD Grade 2, Group A)?

Triple therapy: ICS + LABA + LAMA
Long-acting muscarinic antagonist (LAMA) monotherapy (Correct answer)
Inhaled corticosteroid (ICS) monotherapy
Short-acting bronchodilator as needed

Correct answer: Long-acting muscarinic antagonist (LAMA) monotherapy

GOLD 2023 recommends a bronchodilator (either LAMA or LABA) for Group A patients. LAMA monotherapy (e.g., tiotropium) is preferred for maintenance because it reduces exacerbations and improves lung function. ICS is not recommended as monotherapy in COPD due to lack of efficacy and risk of pneumonia. Triple therapy is reserved for Group E patients with persistent symptoms and frequent exacerbations.

Question 129: A pharmacist reviews a prescription for clopidogrel in a patient on omeprazole. What is the clinical significance of this interaction?

Omeprazole reduces clopidogrel absorption by raising gastric pH
Omeprazole inhibits CYP2C19, reducing conversion of clopidogrel to its active metabolite (Correct answer)
Omeprazole induces CYP2C19, increasing clopidogrel's active metabolite
The interaction only applies to IV omeprazole formulations

Correct answer: Omeprazole inhibits CYP2C19, reducing conversion of clopidogrel to its active metabolite

Omeprazole inhibits CYP2C19, the enzyme responsible for converting clopidogrel to its active thiol metabolite, potentially reducing antiplatelet efficacy.

Question 130: Which fluoroquinolone interaction most significantly prolongs the QT interval and requires monitoring?

Levofloxacin with warfarin
Ciprofloxacin with antacids
Ciprofloxacin with metformin
Moxifloxacin with amiodarone (Correct answer)

Correct answer: Moxifloxacin with amiodarone

Moxifloxacin combined with amiodarone poses a serious additive QT prolongation risk that can lead to torsades de pointes.

Question 131: Which laboratory finding would be an absolute contraindication to initiating an aldosterone antagonist in a patient with HFrEF?

Hemoglobin <10 g/dL
Serum sodium <135 mEq/L
Serum potassium ≥5.0 mEq/L or eGFR <30 mL/min (Correct answer)
Total bilirubin >2 mg/dL

Correct answer: Serum potassium ≥5.0 mEq/L or eGFR <30 mL/min

Aldosterone antagonists are contraindicated when serum potassium is ≥5.0 mEq/L due to severe hyperkalemia risk, or when eGFR is <30 mL/min due to impaired potassium excretion.

Question 132: A 70-year-old patient with chronic stable angina is optimally treated with metoprolol succinate and amlodipine but remains symptomatic. What is the most appropriate add-on antianginal therapy?

Either ranolazine or a long-acting nitrate are appropriate add-on options (Correct answer)
Ranolazine
Long-acting nitrate
Ivabradine (if HR >70 bpm and sinus rhythm)

Correct answer: Either ranolazine or a long-acting nitrate are appropriate add-on options

Both ranolazine and long-acting nitrates are appropriate add-on antianginal agents when patients remain symptomatic on beta-blocker plus calcium channel blocker therapy.

Question 133: A patient on rosuvastatin 20 mg develops unexplained muscle pain. CK is 12,000 U/L. What is the most appropriate action?

Add CoQ10 and continue rosuvastatin
Reduce rosuvastatin to 10 mg
Discontinue rosuvastatin immediately (Correct answer)
Switch to pravastatin 40 mg

Correct answer: Discontinue rosuvastatin immediately

Markedly elevated CK (>10× ULN) with muscle symptoms indicates myopathy/rhabdomyolysis and requires immediate statin discontinuation.

Question 134: Andexanet alfa (Andexxa) is FDA-approved for reversal of which anticoagulants in life-threatening bleeding?

Warfarin and fondaparinux
Unfractionated heparin and enoxaparin
Dabigatran and argatroban
Rivaroxaban and apixaban (Correct answer)

Correct answer: Rivaroxaban and apixaban

Andexanet alfa is a modified recombinant Factor Xa decoy protein approved for reversing rivaroxaban and apixaban (both Factor Xa inhibitors) in life-threatening bleeding.

Question 135: A pharmacist is developing a program to improve medication adherence for a population of older adults with complex, multi-drug regimens for various chronic conditions. Which single intervention is most effective for specifically addressing non-adherence due to regimen complexity?

Conducting one intensive education session at the start of therapy.
Providing generic medication alternatives to reduce cost.
Using multi-dose packaging or pill organizers. (Correct answer)
Sending daily automated text message reminders.

Correct answer: Using multi-dose packaging or pill organizers.

For non-adherence caused specifically by the complexity of a regimen, simplification is the most direct and effective strategy. Multi-dose packaging (e.g., blister packs) or pill organizers directly address this barrier by pre-sorting medications, reducing the cognitive burden on the patient. While cost reduction (B) and reminders (C) are useful for other adherence barriers, they do not simplify the physical act of taking many pills. A single education session (D) is often insufficient for long-term retention with complex regimens.

Question 136: Which antimicrobial is first-line for treatment of Clostridioides difficile (C. diff) infection of non-severe initial episodes per IDSA/SHEA guidelines?

Oral vancomycin or fidaxomicin (Correct answer)
Ciprofloxacin
Clindamycin
Metronidazole (IV)

Correct answer: Oral vancomycin or fidaxomicin

IDSA/SHEA guidelines recommend oral vancomycin or fidaxomicin over metronidazole for initial non-severe C. difficile infection due to superior cure rates.

Question 137: A pharmacist identifies that a patient's poor glycemic control is due to cost barriers preventing insulin purchase. What is the MOST appropriate next step?

Document non-adherence and notify the physician
Connect the patient with manufacturer patient assistance programs and low-cost insulin options (Correct answer)
Switch the patient to a less effective but cheaper oral agent without physician involvement
Advise the patient to ration their current insulin supply

Correct answer: Connect the patient with manufacturer patient assistance programs and low-cost insulin options

Addressing financial barriers through assistance programs is within the pharmacist's scope and directly resolves the identified root cause of non-adherence.

Question 138: Pre-exposure prophylaxis (PrEP) with tenofovir/emtricitabine (Truvada) is indicated for which patient population?

HIV-negative individuals at high risk for HIV acquisition (Correct answer)
All sexually active adults regardless of risk
HIV-positive individuals on ART
Patients with chronic hepatitis C

Correct answer: HIV-negative individuals at high risk for HIV acquisition

PrEP is indicated for HIV-negative adults at substantial ongoing risk of HIV, such as those with high-risk sexual behavior or injection drug use.

Question 139: A patient asks about receiving the COVID-19 vaccine during a routine ambulatory visit. Which statement accurately reflects current vaccination guidance?

COVID-19 vaccines require a 4-week interval before any other vaccine
Only individuals over 65 need the COVID-19 vaccine
COVID-19 vaccines should not be co-administered with other vaccines
Updated COVID-19 vaccines can be co-administered with other vaccines at the same visit (Correct answer)

Correct answer: Updated COVID-19 vaccines can be co-administered with other vaccines at the same visit

CDC guidance states that COVID-19 vaccines may be co-administered with other vaccines without waiting periods.

Question 140: Which study design provides the highest level of evidence for evaluating therapeutic interventions?

Expert opinion
Case-control study
Well-designed cohort study
Systematic review with meta-analysis of randomized controlled trials (Correct answer)

Correct answer: Systematic review with meta-analysis of randomized controlled trials

Systematic reviews with meta-analyses of RCTs sit at the top of the evidence hierarchy for therapeutic questions.

Question 141: Which GLP-1 receptor agonist is FDA-approved for once-weekly subcutaneous injection and has demonstrated cardiovascular outcome benefits in the LEADER trial?

Semaglutide
Dulaglutide
Exenatide extended-release
Liraglutide (Correct answer)

Correct answer: Liraglutide

Liraglutide (Victoza) was studied in the LEADER trial, demonstrating significant reduction in major adverse cardiovascular events in high-risk T2DM patients.

Question 142: The FOURIER trial demonstrated cardiovascular benefit for which medication class in patients with established ASCVD on statin therapy?

SGLT2 inhibitors
Fibrates
PCSK9 inhibitors (Correct answer)
Omega-3 fatty acids

Correct answer: PCSK9 inhibitors

FOURIER showed that evolocumab (a PCSK9 inhibitor) significantly reduced major CV events in patients with ASCVD already on statin therapy.

Question 143: Which direct oral anticoagulant (DOAC) requires dose adjustment based on a combination of age, weight, AND serum creatinine?

Apixaban (Correct answer)
Dabigatran
Edoxaban
Rivaroxaban

Correct answer: Apixaban

Apixaban dose reduction requires meeting at least 2 of 3 criteria: age ≥80, weight ≤60 kg, or serum creatinine ≥1.5 mg/dL.

Question 144: A patient taking apixaban requires emergent surgery within 8 hours after a serious fall. Which is the most appropriate reversal strategy?

Andexanet alfa per weight-based dosing protocol (Correct answer)
Protamine sulfate IV bolus
Idarucizumab 5 g IV
Vitamin K 10 mg IV infusion

Correct answer: Andexanet alfa per weight-based dosing protocol

Andexanet alfa is the FDA-approved specific reversal agent for apixaban and rivaroxaban, indicated for life-threatening or urgent surgical bleeding situations.

Question 145: Which DOAC has the lowest proportion of renal elimination (~27%), making it most suitable in patients with chronic kidney disease?

Apixaban (Correct answer)
Dabigatran
Edoxaban
Rivaroxaban

Correct answer: Apixaban

Apixaban has approximately 27% renal elimination, the lowest among the four approved DOACs, compared to dabigatran (~80%), making it most favorable in CKD patients.

Question 146: Which reimbursement mechanism most directly supports pharmacist-provided Medication Therapy Management (MTM) services under Medicare?

Medicare Part B incident-to billing
Medicare Advantage supplemental benefit payments
Medicare Part D standalone MTM program funding (Correct answer)
Medicare Part A inpatient DRG payments

Correct answer: Medicare Part D standalone MTM program funding

Medicare Part D requires Prescription Drug Plans to provide MTM programs for targeted beneficiaries, funding pharmacist-delivered services.

Question 147: Which beta-blocker is considered cardioselective and preferred in a patient with mild asthma requiring treatment for hypertension?

Propranolol
Sotalol
Carvedilol
Metoprolol succinate (Correct answer)

Correct answer: Metoprolol succinate

Metoprolol succinate is cardioselective (beta-1 selective) at recommended doses, making it preferable over non-selective beta-blockers in patients with reactive airway disease, though caution is still warranted.

Question 148: Which antihypertensive combination is generally AVOIDED due to risk of hyperkalemia, acute kidney injury, and hypotension?

Beta-blocker + thiazide
ARB + thiazide diuretic
ACE inhibitor + ARB (Correct answer)
ACE inhibitor + CCB

Correct answer: ACE inhibitor + ARB

Dual RAAS blockade combining an ACE inhibitor with an ARB increases risk of hyperkalemia, AKI, and hypotension without additional CV benefit.

Question 149: When presenting a business plan to hospital administration to justify the creation of a new pharmacist-led transitional care management (TCM) service, which of the following provides the strongest argument for a positive return on investment (ROI)?

The number of medication discrepancies identified and resolved by the pharmacist.
Projected number of patients enrolled in the first year.
High patient satisfaction scores reported on post-discharge surveys.
Demonstrated cost avoidance through a reduction in preventable hospital readmissions. (Correct answer)

Correct answer: Demonstrated cost avoidance through a reduction in preventable hospital readmissions.

While enrollment numbers, satisfaction scores, and process measures are important, the most compelling metric for demonstrating financial ROI to administration is cost avoidance. Reducing costly, and often penalized, hospital readmissions provides a clear and significant financial benefit that can be directly compared against the operational costs of the new pharmacy service.

Question 150: Which patient population is at HIGHEST risk for health literacy-related medication errors?

Middle-aged patients taking a single medication
Young adults with college education
Elderly patients with multiple chronic conditions and low educational attainment (Correct answer)
Patients who use smartphones for health information

Correct answer: Elderly patients with multiple chronic conditions and low educational attainment

Elderly patients with multiple chronic conditions and lower formal education are disproportionately affected by limited health literacy, increasing medication error risk.

Board Certified Ambulatory Care Pharmacist (BCACP) Exam

The BCACP certification, administered by the Board of Pharmacy Specialties (BPS), validates a pharmacist's advanced competency in ambulatory care practice including patient-centered medication therapy management, clinical literature interpretation, and population-based care.

150

Questions

225 min

Time Limit

62%

To Pass

Checking for saved progress...

Exam Rules

You can skip questions and return to them later
Flag questions for review before submitting
No feedback shown until you submit the entire exam
Unanswered questions count as wrong — answer everything
10 pretest questions are mixed in and don't affect your score
Timer auto-submits when time runs out
Your progress is auto-saved every 30 seconds